Toggle light / dark theme

Summary: Researchers have discovered that positive emotions enhance perceptual memories during sleep, particularly in the non-REM stage. Using mice, they found that memories linked to rewarding experiences lasted longer than neutral ones. The amygdala plays a key role in strengthening these memories by activating a tri-regional circuit with the motor and sensory cortices.

Brain recordings confirmed that this circuit reactivates during non-REM sleep, solidifying perceptual memories. Blocking amygdala signals during non-REM sleep disrupted memory retention, while blocking them during REM sleep had no effect. These findings suggest new ways to treat conditions like addiction and PTSD by targeting non-REM sleep processes.

A study confirms the positive effects of exercise on insulinInsulin is a hormone produced by the pancreas, crucial for regulating blood glucose levels. It helps cells in the body absorb glucose from the bloodstream and convert it into energy or store it for future use. Insulin production and action are essential for maintaining stable blood sugar levels. In people with diabetes, the body either does not produce enough insulin (Type 1 diabetes) or cannot effectively use the insulin it does produce (Type 2 diabetes), leading to elevated levels of glucose in the blood. This can cause various health complications over time, including heart disease, kidney damage, and nerve dysfunction. Insulin therapy, where insulin is administered through injections or an insulin pump, is a common treatment for managing diabetes, particularly Type 1. The discovery of insulin in 1921 by Frederick Banting and Charles Best was a landmark in medical science, transforming diabetes from a fatal disease to a manageable condition. tabindex=0 insulin signaling proteins in the brain.

Researchers recently discovered that eight different psychiatric conditions share a common genetic basis.

A new study has now honed in on some of those shared genetic variants to understand their properties. They found many are active for longer during brain development and potentially impact multiple stages, suggesting they could be new targets to treat multiple conditions.

“The proteins produced by these genes are also highly connected to other proteins,” explains University of North Carolina geneticist Hyejung Won. “Changes to these proteins in particular could ripple through the network, potentially causing widespread effects on the brain.”

A recent study from the University of California San Diego School of Medicine has provided fresh insight into the potential benefits of time-restricted feeding in managing these circadian disruptions.

This approach, which involves eating within a specific daily window, could offer a novel way to address Alzheimer’s symptoms and possibly alter the course of the disease itself. The findings challenge traditional perspectives on the disorder, shifting attention to the importance of daily eating habits.

The circadian rhythm functions as the body’s internal biological clock, regulating numerous physiological processes, including the sleep-wake cycle. Disruptions to this rhythm are particularly common among Alzheimer’s patients, with recent estimates suggesting that up to 80% experience these disturbances. These disruptions not only interfere with sleep but also contribute to increased cognitive impairment, particularly during nighttime hours.

Summary: Scientists have discovered that neural stem cells (NSCs) receive constant feedback from their daughter cells, influencing whether they remain dormant or activate to form new neurons and glia. This parent-child relationship helps regulate brain regeneration and repair.

The study also reveals that calcium signaling plays a key role in how NSCs decode multiple signals from their environment. If NSCs produce only a few daughter cells, they activate; if they produce many, they stay dormant.

These findings challenge previous assumptions that NSCs function independently and open new avenues for treating neurodevelopmental disorders. Future research will explore how these processes change in aging and disease.

A new technology developed at MIT enables scientists to label proteins across millions of individual cells in fully intact 3D tissues with unprecedented speed, uniformity, and versatility. Using the technology, the team was able to richly label large tissue samples in a single day. In their new study in Nature Biotechnology, they also demonstrate that the ability to label proteins with antibodies at the single-cell level across large tissue samples can reveal insights left hidden by other widely used labeling methods.

Profiling the proteins that cells are making is a staple of studies in biology, neuroscience, and related fields because the proteins a cell is expressing at a given moment can reflect the functions the cell is trying to perform or its response to its circumstances, such as disease or treatment. As much as microscopy and labeling technologies have advanced, enabling innumerable discoveries, scientists have still lacked a reliable and practical way of tracking protein expression at the level of millions of densely packed individual cells in whole, 3D intact tissues. Often confined to thin tissue sections under slides, scientists therefore haven’t had tools to thoroughly appreciate cellular protein expression in the whole, connected systems in which it occurs.

“Conventionally, investigating the molecules within cells requires dissociating tissue into single cells or slicing it into thin sections, as light and chemicals required for analysis cannot penetrate deep into tissues. Our lab developed technologies such as CLARITY and SHIELD, which enable investigation of whole organs by rendering them transparent, but we now needed a way to chemically label whole organs to gain useful scientific insights,” says study senior author Kwanghun Chung, associate professor in The Picower Institute for Learning and Memory, the departments of Chemical Engineering and Brain and Cognitive Sciences, and the Institute for Medical Engineering and Science at MIT. “If cells within a tissue are not uniformly processed, they cannot be quantitatively compared. In conventional protein labeling, it can take weeks for these molecules to diffuse into intact organs, making uniform chemical processing of organ-scale tissues virtually impossible and extremely slow.”